4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Daxor Corporation (DXR) operates in the Medical Instruments & Supplies industry and is headquartered in Oak Ridge, United States. Its market capitalization is roughly $59 million. In the fiscal year ended 2025-12-31, DXR reported $10M in revenue and $9M in net income.
Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit.
Interactive charts & full statements → Open the DXR valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $10M | $2M | $1M | $6M |
| Net Income | $9M | $0M | $0M | $5M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $46M | $37M | $35M | $30M | — |
| Total Liabilities | $0M | $1M | $1M | $1M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive DXR viewer.
About TickerBase · Data methodology & sources